journal article·2024-03-08Open access

Radiomic-Based Biomarkers for the Evaluation of Prosthetic Heart Valve Infective Endocarditis in Non-Attenuation Correction [18F]FDG PET/CT Images

David Palomino-Fernández, Adolfo Gómez-Grande, Alexander P. Seiffert, Héctor Bueno, Enrique J. Gómez, Patricia Sánchez-González

Applied Sciences· Volume 14· Issue 6

Abstract

Although there have been crucial advancements in the diagnostic and treatment approaches, the mortality rate of infective endocarditis is still an ongoing challenge in clinical practice. [18F]FDG PET/CT imaging has recently proven its potential role in the early identification of prosthetic valve endocarditis (PVE). Due to radiomics’ rising applicability, recent studies exhibit promising outcomes in the clinical setting. The aim of the present study is the evaluation of potential radiomic-based biomarkers of non-attenuation-corrected (NAC) [18F]FDG PET images for the diagnosis of PVE. An adequate pre-processing and segmentation of the prosthetic ring metabolic activity were performed. A reproducibility analysis prior to the image-based biomarkers’ identification was conducted in terms of the intraclass correlation coefficient (ICC) derived from the variations in the radiomic extraction configurations (bin number and voxel size). After the reliability analysis, statistical analysis was performed by means of the Mann–Whitney U Test to study the differences between the PVE groups. Only p values < 0.05 after the Benjamini Hochberg correction procedure for multiple comparisons were considered statistically significant. Eight ML classification models for PVE classification based on radiomic features were evaluated. Overall, 45.2% and 95.7% of the radiomic features showed a consistency ICC above 0.82, demonstrating great reproducibility against variations in the bin number and interpolation thickness, respectively. Variations in interpolation thickness demonstrated great reproducibility in absolute agreement with 80.0% robust features, proving a non-dependency relationship with radiomic values. In the present study, the utility of potential radiomic-based biomarkers in the diagnosis of PVE in NAC [18F]FDG PET/CT images has been evaluated. Future studies will be required to validate the use of this technology as a valuable tool to support the current PVE diagnostic criteria.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced X-ray and CT Imaging · Infective Endocarditis Diagnosis and Management · Orthopedic Infections and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Biomedical Engineering and Telemedicine Centre, ETSI Telecomunicación, Center for Biomedical Technology, Universidad Politécnica de Madrid, 28040 Madrid, Spain

Department of Nuclear Medicine, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain

Centro Nacional de Investigaciones Cardiovasculares (CNIC), 29029 Madrid, Spain

Cardiology Department, Instituto de Investigación Sanitaria (imas12), Hospital Universitario 12 de Octubre, 28041 Madrid, Spain

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain

Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain

Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, 28029 Madrid, Spain

Funding

Sociedad Española de Cardiología

References (49)

Show source-provided references
1. Infective endocarditis10.1038/nrdp.2016.59 ↗
2. Positron Emission Tomography/Computed Tomography for Diagnosis of Prosthetic Valve Endocarditis10.1016/j.jacc.2013.06.069 ↗
3. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)10.1093/eurheartj/ehv319 ↗
4. Recommendations for the practice of echocardiography in infective endocarditis10.1093/ejechocard/jeq004 ↗
5. Value and limitations of the duke criteria for the diagnosis of infective endocarditis10.1016/S0735-1097(99)00116-3 ↗
6. Contribution of Systematic Serological Testing in Diagnosis of Infective Endocarditis10.1128/JCM.43.10.5238-5242.2005 ↗
7. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications10.1161/CIR.0000000000000296 ↗
8. Imaging of Endocarditis and Cardiac Device-Related Infections: An Update10.1053/j.semnuclmed.2023.01.001 ↗
9. The Role of 18-F FDG PET/CT in Imaging of Endocarditis and Cardiac Device Infections10.1053/j.semnuclmed.2020.03.003 ↗
10. The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis
11. Morpho-metabolic post-surgical patterns of non-infected prosthetic heart valves by [18F]FDG PET/CTA: “normality” is a possible diagnosis10.1093/ehjci/jez222 ↗
12. Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series10.1186/1756-0500-7-32 ↗
13. Diagnostics of “non-acute” vascular prosthesis infection using 18F-FDG PET/CT: Our experience with 96 prostheses10.1007/s00259-008-1002-z ↗
14. Kamani, C.H., Allenbach, G., Jreige, M., Pavon, A.G., Meyer, M., Testart, N., Firsova, M., Vieira, V.F., Boughdad, S., and Lalonde, M.N. (2020). Diagnostic Performance of 18F-FDG PET/CT in Native Valve Endocarditis: Systematic Review and Bivariate Meta-Analysis. Diagnostics, 10.10.3390/diagnostics10100754 ↗
15. Diagnosis of blood culture-negative endocarditis and clinical comparison between blood culture-negative and blood culture-positive cases10.1007/s15010-015-0863-x ↗
16. Diagnostic criteria and problems in infective endocarditis10.1136/hrt.2003.029850 ↗
17. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis10.1007/s12350-017-1092-8 ↗
18. [18F]FDG-PET CT for the evaluation of native valve endocarditis10.1007/s12350-020-02092-6 ↗
19. Diagnostic Accuracy of 18F-FDG PET/CT in Infective Endocarditis and Implantable Cardiac Electronic Device Infection: A Cross-Sectional Study10.2967/jnumed.116.173690 ↗
20. Infective endocarditis detected by 18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography in a patient with occult infection10.1016/j.kjms.2011.06.018 ↗
21. Utilization of FDG-PET/CT in the diagnosis of native valve endocarditis: There is a hope, but we need more data!10.1007/s12350-020-02308-9 ↗
22. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: Comparison with computed tomographic findings10.1016/j.jvs.2005.07.038 ↗
23. Distinguishing Active Vasculitis from Sterile Inflammation and Graft Infection10.1016/j.jcmg.2017.07.006 ↗
24. Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices with 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography10.1161/CIRCULATIONAHA.115.015316 ↗
25. CASSIA (cardiology software suite for image analysis): A potential new tool for the evaluation of [18F]FDG PET/CT in the setting of infective endocarditis10.1007/s11548-022-02729-6 ↗
26. Standardized uptake values in FDG PET/CT for prosthetic heart valve endocarditis: A call for standardization10.1007/s12350-017-0932-x ↗
27. The Emerging Role of FDG PET/CT in Diagnosing Endocarditis and Cardiac Device Infection10.1016/j.cpcardiol.2022.101510 ↗
28. The role of 18F-FDG PET/CT in infectious endocarditis: A systematic review and meta-analysis10.5414/CP202569 ↗
29. 18F-FDG PET/CT in Infective Endocarditis: Indications and Approaches for Standardization10.1007/s11886-021-01542-y ↗
30. A review in radiomics: Making personalized medicine a reality via routine imaging10.1002/med.21846 ↗
31. Radiomics: The bridge between medical imaging and personalized medicine10.1038/nrclinonc.2017.141 ↗
32. Radiomics: From qualitative to quantitative imaging10.1259/bjr.20190948 ↗
33. Machine Learning and Deep Learning in Medical Imaging: Intelligent Imaging10.1016/j.jmir.2019.09.005 ↗
34. [18F]FDG-PET/CT radiomics in patients suspected of infective endocarditis10.1093/ehjci/jeab289.443 ↗
35. 18F-FDG-Based Radiomics and Machine Learning10.1016/j.jcmg.2023.01.020 ↗
36. Suppression of Myocardial 18F-FDG Uptake by Preparing Patients with a High-Fat, Low-Carbohydrate Diet10.2214/AJR.07.2409 ↗
37. Attenuation correction and metal artifact reduction in FDG PET/CT for prosthetic heart valve and cardiac implantable device endocarditis10.1007/s12350-017-1176-5 ↗
38. The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping10.1148/radiol.2020191145 ↗
39. Palomino-Fernández, D., Seiffert, A.P., Gómez-Grande, A., López-Guarch, C.J., Moreno, G., Bueno, H., Gómez, E.J., and Sánchez-González, P. (2024). Robustness of [18F]FDG PET/CT radiomic analysis in the setting of drug-induced cardiotoxicity. Comput. Methods Programs Biomed., 244.10.1016/j.cmpb.2023.107981 ↗
40. Stability of Radiomic Features across Different Region of Interest Sizes—A CT and MR Phantom Study10.3390/tomography7020022 ↗
41. Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation10.1007/s11307-016-0940-2 ↗
42. Robustness of radiomic features in CT images with different slice thickness, comparing liver tumour and muscle10.1038/s41598-021-87598-w ↗
43. Computational radiomics system to decode the radiographic phenotype10.1158/0008-5472.CAN-17-0339 ↗
44. SMOTE: Synthetic Minority Over-sampling Technique10.1613/jair.953 ↗
45. Criteria for the translation of radiomics into clinically useful tests10.1038/s41571-022-00707-0 ↗
46. CheckList for EvaluAtion of Radiomics research (CLEAR): A step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII10.1186/s13244-023-01415-8 ↗
47. Sample size, power and effect size revisited: Simplified and practical approaches in pre-clinical, clinical and laboratory studies10.11613/BM.2021.010502 ↗
48. Lin, W.-J., Hsueh, H.-M., and Chen, J.J. (2010). Power and sample size estimation in microarray studies. BMC Bioinform., 11.10.1186/1471-2105-11-48 ↗
49. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences10.3758/BF03193146 ↗